CASTLE BIOSCIENCES, INC.
Ownership & governance
Executives 5Directors 8Avg age 63Avg tenure 8.1y
DM
Derek Maetzold
Chief Executive Officer
Age 64Since 2007-08-31Profile →
+12
Executives5
Board of directors8
DM
Derek Maetzold→
Director/Board Member
Age 64Since 2007-08-31
DB
Daniel Bradbury→
Chairman
Age 64Since 2014-08-31
GC
G. Cole→
Director/Board Member
Age 70Since 2018-12-05
MH
Miles Harrison→
Director/Board Member
Age 61Since 2020-03-31
TO
Tiffany Olson→
Director/Board Member
Age 66Since 2021-05-07
KC
Kimberlee Caple→
Director/Board Member
Age 64Since 2021-07-15
EG
Ellen Goldberg→
Director/Board Member
Age 52Since 2021-07-15
RC
Rodney Cotton→
Director/Board Member
Age 66Since 2024-03-25
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| RTW Investments LP | 9.094 % | 2,758,335 |
| BlackRock Advisors LLC | 8.952 % | 2,715,170 |
| Principal Global Investors LLC | 5.835 % | 1,769,877 |
| Portolan Capital Management LLC | 4.452 % | 1,350,283 |
| Vanguard Capital Management LLC | 3.882 % | 1,177,522 |
Catalog · 2026-07-09
Registry officers13
| Name | Role | Since | Shares |
|---|---|---|---|
| Chris Otte | Chief Tech/Sci/R&D Officer | — | - |
| Daniel Bradbury | Chairman | 2014-08-31 | - |
| Derek Maetzold | Chief Executive Officer | 2007-08-31 | - |
| Franklin Stokes | Director of Finance/CFO | 2017-11-30 | - |
| Jennifer Saam | Chief Tech/Sci/R&D Officer | 2024-08-31 | - |
| Johnson Clare | Chief Tech/Sci/R&D Officer | 2021-06-30 | - |
| Derek Maetzold | Director/Board Member | 2007-08-31 | - |
| Ellen Goldberg | Director/Board Member | 2021-07-15 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 45.11Range 35–57Analysts 9
35Mean 45.1157
- Buy 9
Broker actions40 of 76
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | 44 | 2026-08-03 |
| Roth Capital | Initiated | Buy | 40 | 2026-06-25 |
| BTIG | Maintained | Buy | 40 | 2026-05-13 |
| Baird | Maintained | Outperform | 43 | 2026-05-07 |
| Canaccord Genuity | Maintained | Buy | 40 | 2026-04-20 |
| Baird | Maintained | Outperform | 44 | 2026-02-27 |
| Guggenheim | Maintained | Buy | 47 | 2026-01-26 |
| Lake Street | Maintained | Buy | 52 | 2026-01-12 |
| Guggenheim | Maintained | Buy | 43 | 2026-01-05 |
| Canaccord Genuity | Maintained | Buy | 50 | 2025-12-22 |
| BTIG | Maintained | Buy | 50 | 2025-12-12 |
| BTIG | Maintained | Buy | 38 | 2025-11-05 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.